|
AUGUST 2007
|
 |
|
Jeremy D. Buhler
Associate Professor of Computer Science and Engineering
PhD, Computer Science, University of Washington-Seattle, 2001
MS, Computer Science, University of Washington-Seattle, 1998
BA, Computer Science, Rice University, 1996
Jeremy Buhler has been with the Department of Computer Science and Engineering since the fall of 2001. He currently has secondary appointments in the Genetics Department of the Division of Biological and Biomedical Sciences (DBBS) and in the Biology Department in the College of Arts and Sciences.
Professor Buhler's primary research interest lies in developing algorithms to search and analyze the massive amounts of DNA and protein sequence produced by modern molecular biology. In his research, he applies probabilistic, randomized, and approximation-based methods to efficiently automate large-scale tasks in genome annotation, such as comparing multiple sequence alignments and finding subtle regulatory motifs. He also leads projects to accelerate popular sequence analysis algorithms using reconfigurable FPGA hardware.
|
|
Christopher D. Gill
Associate Professor of Computer Science and Engineering
DSc, Computer Science, Washington University in St. Louis, 2002.
MS, Computer Science, University of Missouri-Rolla, 1997
BA, English and Biology, Washington University in St. Louis, 1987
Professor Gill has been with the Department of Computer Science and Engineering since 1997, where he was first a research associate before becoming an assistant professor then an associate professor. Professor Gill spent several years in industry as a software developer and system administrator for companies such as SBC Communications (now AT&T), Teknivent Corp., Saleskit Software, and Prudential Group Health.
Professor Gill’s research focuses on assuring properties of distributed real-time and embedded systems in which software complexity, unpredictable environments, and heterogeneous platforms demand novel solutions that are grounded in sound theory. A major goal of his work is to assure that constraints on timing, memory footprint, fault-tolerance, and other system properties can be met when system software is re-used across heterogeneous applications, operating environments, and deployment platforms.
Professor Gill is a recipient of the National Science Foundation CAREER Award.
|
|
Cindy M. Grimm
Associate Professor of Computer Science and Engineering
PhD, Computer Science, Brown University, 1996
MA, Computer Science, Brown University, 1992
BA, Computer Science, University of California-Berkley, 1990
BA, Art, University of California-Berkley, 1990
Prior to joining Washington University in 2000, Professor Grimm was a post-doctoral researcher at Brown University and at Microsoft. She also held research assistant and lecturer positions at Brown.
Professor Grimm’s research interests include surface modeling and illustrative rendering. She has developed manifolds for constructive surface building and analysis. She creates perceptual editing tools that support more intelligent manipulation of visual effects in scenes, and camera controls that support more effective display of data through the use of non-linear perspective.
Professor Grimm is a recipient of the National Science Foundation CAREER Award.
|
|
Rohit V. Pappu
Associate Professor of Biomedical Engineering
Associate Professor of Biochemistry and Molecular Biophysics
PhD, Theoretical and Biological Physics, Tufts University, 1996
MS, Solid State Physics, Tufts University, 1993
BSc, Physics, Mathematics, and Electronics, Bangalore University, 1990
Professor Pappu joined Washington University in 2001, after completion of doctoral studies in Theoretical and Biological Physics at Tufts University. Professor Pappu also completed two postdoctoral fellowships, one at the Department of Biochemistry & Molecular Biophysics at Washington University School of Medicine between 1996 and 1998, and the second in the Department of Biophysics & Biophysical Chemistry at Johns Hopkins University School of Medicine from 1998-2001.
His research focuses on the physics of denatured proteins, protein aggregation, and the role of intrinsically disordered proteins in regulatory and signaling pathways. His research is of direct relevance to the onset and progression of neurodegenerative and systemic diseases such as Huntington’s disease (HD) and Alzheimer’s disease.
|
|
Shelly E. Sakiyama-Elbert
Associate Professor of Biomedical Engineering on the Joseph and Florence Farrow Endowment
Associate Professor of Energy, Environmental, and Chemical Engineering
Associate Professor of Surgery
PhD, Chemical Engineering, California Institute of Technology, 2000
MS, Chemical Engineering, California Institute of Technology, 1998
BS, Chemical Engineering and Biology, Massachusetts Institute of Technology, 1996
Professor Sakiyama-Elbert joined Washington University in 2000. She is a member of the Center for Materials Innovation and the Hope Center for Neurological Disorders.
Professor Sakiyama-Elbert's research is highly interdisciplinary, combining an understanding of biology, chemistry, and biomedical engineering to develop new bioactive materials, which can enhance wound healing and tissue regeneration. Her research also includes drug delivery, gene delivery, and stem cell research. Her research is currently funded by the NIH and Wallace H. Coulter Foundation. She currently serves as the Vice President of Tissue Engineering Special Interest Group in the Society for Biomaterials.
|
|
David Sept
Associate Professor of Biomedical Engineering
Associate Professor of Energy, Environmental, and Chemical Engineering
Associate Professor of Biochemistry, Molecular Biophysics, and Physics
PhD, Theoretical Physics, University of Alberta, 1997
BS, Physics, University of Alberta, 1992
Professor Sept joined Washington University in 2001; prior to coming to WU, he was a postdoctoral fellow at the University of California-San Diego from 1997-2001.
Using computer simulation techniques, Professor Sept is working to understand the dynamics, function, and organization of proteins within the cell. He is particularly interested in the molecular details of how polymers form and how they are regulated within the cell by drugs, small molecules, and other proteins. These factors have a direct bearing on the development of therapeutic agents since controlling the stability of microtubules is one of the primary methods of treating diseases, such as cancer. He is also working to develop new drugs for use in combating parasitic diseases, such as malaria.
|
|
|
